CML is primarily caused by a genetic mutation known as the Philadelphia chromosome. This abnormality results from a translocation between chromosomes 9 and 22, creating the BCR-ABL fusion gene. The product of this fusion gene is an abnormal tyrosine kinase enzyme that promotes the growth of cancerous cells.
